Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
CGTX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -71.5%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
cognition
therapeutics
announced
after
alzheimer
results
trading
2024
disease
clinical
gained
market
study
2023
rose
million
offering
nyse
phase
CGTX
Cognition Therapeutics, Inc. Common Stock
StonvexStonvexStonvexStonvex